Warehousers Beware: Peak Demand May Occur Outside the Holiday Season

As evidenced by record sales this last Black Friday, consumer demand for online shopping has never been higher. And thankfully for Christmas shoppers all over the world, retail supply chains are rebounded from pandemic levels. Walmart, Sam’s Club and Target all claimed their inventories are primed to meet peak demand, and will now have those promises put to the test as online Black Friday and Cyber Monday orders flood through the logistics pipeline.

While this is particularly timely to start the holiday shopping season, Leigh Chesley, Chief Customer Officer at Longbow Advantage, reminds retailers that warehouses need to be cognizant of changing dynamics around peak demand; peaks are no longer a seasonal phenomenon. Rather, peaks can occur at anytime throughout the year as consumers’ purchasing decisions become more fluid, thanks in large part to inflation.

Leigh’s Thoughts

“What we’re finding is that peak has almost become a year round thing. So whereas before people were really putting a lot of inventory into their warehouses leading up to peak, we’re finding that warehouses are actually much more utilized from a percentage perspective year-round as opposed to just at peak.

What we’re also seeing on the retail side is that inflation is really starting to impact how consumers are making purchasing decision. So whereas people may have had larger budgets in the past, they might be pulling back on their spending for this year, or they’re making different spending decisions where they might have bought a more premium item, they’re looking for something a little bit different.

So that’s where we’re seeing a lot of warehousing, where folks are, again, bringing that inventory up because while what may have been anticipated or expected in the past, even as folks were looking at planning a few months ago, they’re starting to see that consumers are still spending, they’re just spending differently.

And so they need to be prepared for the shifts that are happening within the consumer base, really at a real time speed so that they can adjust and make sure that they’re getting the right things either on the shelves or in the mail direct to consumers as well.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More